Michał Bochenek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michał Bochenek has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Artur Gurgul
Department of Basic Sciences, University of Agriculture in Krakow, Krakow, Poland
2 shared publications Adithya Sridhar
OrganoVIR Labs, Emma Children’s Hospital, Department of Pediatric Infectious Diseases, Amsterdam University Medical Center, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam
1 shared publication- Agnieszka Bernat
Department of Experimental Embryology Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences Magdalenka Poland
1 shared publication - Agnieszka Robaszkiewicz
Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland
1 shared publication - Aleksandra Synowiec
Virogenetics Laboratory of Virology, Małopolska Centre of Biotechnology, Jagiellonian University
1 shared publication Anna Bodzoń-Kułakowska
Department of Biochemistry and Neurobiology, Akademia Górniczo-Hutnicza University of Science and Technology, 30-059 Krakow, Poland
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (26)
Temperature and developmental stage govern intestinal susceptibility to human coronavirus 229E
Human coronaviruses have been primarily associated with upper respiratory tract infections, yet cases of gastrointestinal symptoms in COVID-19 patients have highlighted their potential to cause systemic disease. Here, we detail the infection of intestinal epithelia by an endemic, low-pathogenic human coronavirus, human alphacoronavirus 229E, using patient-derived human intestinal enteroids (HIEs) from donors of various ages. Using fetal, pediatric, and adult HIEs, we investigated how physiologically relevant temperatures: 37 °C and 32 °C, reflecting gastrointestinal and upper-airway conditions, respectively, modulate epithelial responses and viral infection dynamics. We show that there is temperature-dependent transcriptional reprogramming, indicating strong temperature-dependent regulation of virus replication and epithelial responses. Among the seasonal coronaviruses tested, only HCoV-229E productively infects HIEs. At 32 °C, HCoV-229E replicates efficiently in enteroids from all donor ages and releases high titers of infectious progeny. In contrast, at 37 °C, productive replication is largely confined to fetal and a subset of pediatric tissues, revealing a developmental and temperature-sensitive restriction on infection. Confocal and flow cytometry analyses identify enterocytes as the primary target cells for HCoV-229E. Furthermore, we show that camostat, a serine protease inhibitor, significantly reduces HCoV-229E replication in HIEs, confirming a critical role for host serine protease activity. Collectively, these findings establish HIEs as a relevant model for HCoV-229E–host interactions and reveal temperature- and age-dependent determinants governing intestinal permissiveness to this seasonal coronavirus.
- 24 June 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (26)
Open AccessTemperature and developmental stage govern intestinal susceptibility to human coronavirus 229E
Human coronaviruses have been primarily associated with upper respiratory tract infections, yet cases of gastrointestinal symptoms in COVID-19 patients have highlighted their potential to cause systemic disease. Here, we detail the infection of intestinal epithelia by an endemic, low-pathogenic human coronavirus, human alphacoronavirus 229E, using patient-derived human intestinal enteroids (HIEs) from donors of various ages. Using fetal, pediatric, and adult HIEs, we investigated how physiologically relevant temperatures: 37 °C and 32 °C, reflecting gastrointestinal and upper-airway conditions, respectively, modulate epithelial responses and viral infection dynamics. We show that there is temperature-dependent transcriptional reprogramming, indicating strong temperature-dependent regulation of virus replication and epithelial responses. Among the seasonal coronaviruses tested, only HCoV-229E productively infects HIEs. At 32 °C, HCoV-229E replicates efficiently in enteroids from all donor ages and releases high titers of infectious progeny. In contrast, at 37 °C, productive replication is largely confined to fetal and a subset of pediatric tissues, revealing a developmental and temperature-sensitive restriction on infection. Confocal and flow cytometry analyses identify enterocytes as the primary target cells for HCoV-229E. Furthermore, we show that camostat, a serine protease inhibitor, significantly reduces HCoV-229E replication in HIEs, confirming a critical role for host serine protease activity. Collectively, these findings establish HIEs as a relevant model for HCoV-229E–host interactions and reveal temperature- and age-dependent determinants governing intestinal permissiveness to this seasonal coronavirus.
- Open Access
- 1 September 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 12677-12697
Swainsonine Protects Human Thyrocytes from Fas-Induced Apoptosis: In vitro Study on Nthy-Ori 3-1 Cell Line
Background: The role of Fas is crucial for preserving immunotolerance. The mechanisms and roles of Fas/FasL signaling in the immune system are well understood, but the knowledge of how this process is regulated remains limited. Fas-mediated apoptosis is a way of thyrocyte elimination and thyroid destruction in Hashimoto’s thyroiditis (HT). Proinflammatory cytokines, produced abundantly by immune cells in the thyroid in HT, stimulate the expression of Fas in thyrocytes, making them susceptible to apoptosis induced by FasL on the immune cell surface. Purpose: The present study aimed to evaluate the impact of changes in Fas N-glycosylation on the death of human follicular thyroid cells of the Nthy-ori 3– 1 line. Methods: To induce thyrocyte apoptosis, an in vitro model was established. Cells were stimulated with IFNγ to express Fas and treated with the N-glycosylation inhibitors, kifunensine and swainsonine. Then apoptosis was induced by human recombinant FasL. MALDI-Tof mass spectrometry monitored kifunensine- and swainsonine-induced changes in N-glycosylation of Nthy-ori 3– 1 thyrocytes, and cell death was analyzed using flow cytometry (annexin V staining, caspase 3/7 activity, TMRE mitochondrial membrane potential assay) and fluorescence microscopy (DAPI staining). Results: We found that swainsonine reduces Nthy-ori 3– 1 cell apoptosis, caspase 3 and 7 activity, and restores mitochondrial potential. DAPI staining showed a decreased rupture and fragmentation of Nthy-ori 3– 1 cell nuclei in the presence of swainsonine. The protective effect of kifunensine was only shown in the TMRE assay and for the late apoptotic cells in annexin V+/PI+ staining. Conclusion: Our study demonstrated for the first time the anti-apoptotic effect of swainsonine on follicular thyroid cell death through the Fas/FasL signaling pathway. This finding may have later applications in controlling Fas/FasL-induced thyrocyte apoptosis and preventing thyroid destruction in HT.
- 1 September 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 12677-12697
Open AccessSwainsonine Protects Human Thyrocytes from Fas-Induced Apoptosis: In vitro Study on Nthy-Ori 3-1 Cell Line
Background: The role of Fas is crucial for preserving immunotolerance. The mechanisms and roles of Fas/FasL signaling in the immune system are well understood, but the knowledge of how this process is regulated remains limited. Fas-mediated apoptosis is a way of thyrocyte elimination and thyroid destruction in Hashimoto’s thyroiditis (HT). Proinflammatory cytokines, produced abundantly by immune cells in the thyroid in HT, stimulate the expression of Fas in thyrocytes, making them susceptible to apoptosis induced by FasL on the immune cell surface. Purpose: The present study aimed to evaluate the impact of changes in Fas N-glycosylation on the death of human follicular thyroid cells of the Nthy-ori 3– 1 line. Methods: To induce thyrocyte apoptosis, an in vitro model was established. Cells were stimulated with IFNγ to express Fas and treated with the N-glycosylation inhibitors, kifunensine and swainsonine. Then apoptosis was induced by human recombinant FasL. MALDI-Tof mass spectrometry monitored kifunensine- and swainsonine-induced changes in N-glycosylation of Nthy-ori 3– 1 thyrocytes, and cell death was analyzed using flow cytometry (annexin V staining, caspase 3/7 activity, TMRE mitochondrial membrane potential assay) and fluorescence microscopy (DAPI staining). Results: We found that swainsonine reduces Nthy-ori 3– 1 cell apoptosis, caspase 3 and 7 activity, and restores mitochondrial potential. DAPI staining showed a decreased rupture and fragmentation of Nthy-ori 3– 1 cell nuclei in the presence of swainsonine. The protective effect of kifunensine was only shown in the TMRE assay and for the late apoptotic cells in annexin V+/PI+ staining. Conclusion: Our study demonstrated for the first time the anti-apoptotic effect of swainsonine on follicular thyroid cell death through the Fas/FasL signaling pathway. This finding may have later applications in controlling Fas/FasL-induced thyrocyte apoptosis and preventing thyroid destruction in HT.
- Open Access
Comparative Transcriptome and MicroRNA Profiles of Equine Mesenchymal Stem Cells, Fibroblasts, and Their Extracellular Vesicles
Background: Mesenchymal stem cells (MSCs) are a promising tool in regenerative medicine due to their ability to secrete paracrine factors that modulate tissue repair. Extracellular vesicles (EVs) released by MSCs contain bioactive molecules (e.g., mRNAs, miRNAs, proteins) and play a key role in intercellular communication. Methods: This study compared the transcriptomic profiles (mRNA and miRNA) of equine MSCs derived from adipose tissue (AT-MSCs), bone marrow (BM-MSCs), and ovarian fibroblasts (as a differentiated control). Additionally, miRNAs present in EVs secreted by these cells were characterized using next-generation sequencing. Results: All cell types met ISCT criteria for MSCs, including CD90 expression, lack of MHC II, trilineage differentiation, and adherence. EVs were isolated using ultracentrifugation and validated with nanoparticle tracking analysis and flow cytometry (CD63, CD81). Differential expression analysis revealed distinct mRNA and miRNA profiles across cell types and their secreted EVs, correlating with tissue origin. BM-MSCs showed unique regulation of genes linked to early development and osteogenesis. EVs contained diverse RNA species, including miRNA, mRNA, lncRNA, rRNA, and others. In total, 227 and 256 mature miRNAs were detected in BM-MSCs and AT-MSCs, respectively, including two novel miRNAs per MSC type. Fibroblasts expressed 209 mature miRNAs, including one novel miRNA also found in MSCs. Compared to fibroblasts, 60 and 92 differentially expressed miRNAs were identified in AT-MSCs and BM-MSCs, respectively. Conclusions: The results indicate that MSC tissue origin influences both transcriptomic profiles and EV miRNA content, which may help to interpret their therapeutic potential. Identifying key mRNAs and miRNAs could aid in future optimizing of MSC-based therapies in horses.
Open AccessComparative Transcriptome and MicroRNA Profiles of Equine Mesenchymal Stem Cells, Fibroblasts, and Their Extracellular Vesicles
Background: Mesenchymal stem cells (MSCs) are a promising tool in regenerative medicine due to their ability to secrete paracrine factors that modulate tissue repair. Extracellular vesicles (EVs) released by MSCs contain bioactive molecules (e.g., mRNAs, miRNAs, proteins) and play a key role in intercellular communication. Methods: This study compared the transcriptomic profiles (mRNA and miRNA) of equine MSCs derived from adipose tissue (AT-MSCs), bone marrow (BM-MSCs), and ovarian fibroblasts (as a differentiated control). Additionally, miRNAs present in EVs secreted by these cells were characterized using next-generation sequencing. Results: All cell types met ISCT criteria for MSCs, including CD90 expression, lack of MHC II, trilineage differentiation, and adherence. EVs were isolated using ultracentrifugation and validated with nanoparticle tracking analysis and flow cytometry (CD63, CD81). Differential expression analysis revealed distinct mRNA and miRNA profiles across cell types and their secreted EVs, correlating with tissue origin. BM-MSCs showed unique regulation of genes linked to early development and osteogenesis. EVs contained diverse RNA species, including miRNA, mRNA, lncRNA, rRNA, and others. In total, 227 and 256 mature miRNAs were detected in BM-MSCs and AT-MSCs, respectively, including two novel miRNAs per MSC type. Fibroblasts expressed 209 mature miRNAs, including one novel miRNA also found in MSCs. Compared to fibroblasts, 60 and 92 differentially expressed miRNAs were identified in AT-MSCs and BM-MSCs, respectively. Conclusions: The results indicate that MSC tissue origin influences both transcriptomic profiles and EV miRNA content, which may help to interpret their therapeutic potential. Identifying key mRNAs and miRNAs could aid in future optimizing of MSC-based therapies in horses.
- Open Access
- 9 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Lipid droplets in mammalian eggs are utilized during embryonic diapause
Significance: Lipid droplets (LDs) are stored in the embryo throughout the preimplantation development. Yet, the role of LDs in the embryo remains unknown. Embryonic diapause (ED) is a temporary arrest of an embryo when it waits for the uterine receptivity signal to implant. We provide evidence that LDs play a crucial role in maintaining ED. Diapausing embryos exhibit increased release of exosomes reflecting elevated embryonic signaling to the mother. During ED, the decrease in lipid is caused by a switch from carbohydrate metabolism to lipid catabolism. We have also shown that presence of LDs in the oocytes of various mammals positively corelates with their species-specific length of diapause. Our results reveal the functional role of LDs in embryonic development.
- 9 March 2021
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (10)
Open AccessLipid droplets in mammalian eggs are utilized during embryonic diapause
Significance: Lipid droplets (LDs) are stored in the embryo throughout the preimplantation development. Yet, the role of LDs in the embryo remains unknown. Embryonic diapause (ED) is a temporary arrest of an embryo when it waits for the uterine receptivity signal to implant. We provide evidence that LDs play a crucial role in maintaining ED. Diapausing embryos exhibit increased release of exosomes reflecting elevated embryonic signaling to the mother. During ED, the decrease in lipid is caused by a switch from carbohydrate metabolism to lipid catabolism. We have also shown that presence of LDs in the oocytes of various mammals positively corelates with their species-specific length of diapause. Our results reveal the functional role of LDs in embryonic development.
- Open Access
Embryonic Environmental Niche Reprograms Somatic Cells to Express Pluripotency Markers and Participate in Adult Chimaeras
The phenomenon of the reprogramming of terminally differentiated cells can be achieved by various means, like somatic cell nuclear transfer, cell fusion with a pluripotent cell, or the introduction of pluripotency genes. Here, we present the evidence that somatic cells can attain the expression of pluripotency markers after their introduction into early embryos. Mouse embryonic fibroblasts introduced between blastomeres of cleaving embryos, within two days of in vitro culture, express transcription factors specific to blastocyst lineages, including pluripotency factors. Analysis of donor tissue marker DNA has revealed that the progeny of introduced cells are found in somatic tissues of foetuses and adult chimaeras, providing evidence for cell reprogramming. Analysis of ploidy has shown that in the chimaeras, the progeny of introduced cells are either diploid or tetraploid, the latter indicating cell fusion. The presence of donor DNA in diploid cells from chimaeric embryos proved that the non-fused progeny of introduced fibroblasts persisted in chimaeras, which is evidence of reprogramming by embryonic niche. When adult somatic (cumulus) cells were introduced into early cleavage embryos, the extent of integration was limited and only cell fusion-mediated reprogramming was observed. These results show that both cell fusion and cell interactions with the embryonic niche reprogrammed somatic cells towards pluripotency.
Open AccessEmbryonic Environmental Niche Reprograms Somatic Cells to Express Pluripotency Markers and Participate in Adult Chimaeras
The phenomenon of the reprogramming of terminally differentiated cells can be achieved by various means, like somatic cell nuclear transfer, cell fusion with a pluripotent cell, or the introduction of pluripotency genes. Here, we present the evidence that somatic cells can attain the expression of pluripotency markers after their introduction into early embryos. Mouse embryonic fibroblasts introduced between blastomeres of cleaving embryos, within two days of in vitro culture, express transcription factors specific to blastocyst lineages, including pluripotency factors. Analysis of donor tissue marker DNA has revealed that the progeny of introduced cells are found in somatic tissues of foetuses and adult chimaeras, providing evidence for cell reprogramming. Analysis of ploidy has shown that in the chimaeras, the progeny of introduced cells are either diploid or tetraploid, the latter indicating cell fusion. The presence of donor DNA in diploid cells from chimaeric embryos proved that the non-fused progeny of introduced fibroblasts persisted in chimaeras, which is evidence of reprogramming by embryonic niche. When adult somatic (cumulus) cells were introduced into early cleavage embryos, the extent of integration was limited and only cell fusion-mediated reprogramming was observed. These results show that both cell fusion and cell interactions with the embryonic niche reprogrammed somatic cells towards pluripotency.